Incidental hypermetabolic PET positive lesions in thyroid and pituitary glands in a patient with lung cancer: A case of two uncommon findings in a single patient

Beatty, 2009, Incidental PET/CT findings in the cancer patient: how should they be managed?, Surgery, 146, 274, 10.1016/j.surg.2009.04.024 Agrawal, 2015, Clinical significance of patterns of incidental thyroid uptake at 18 F-FDG PET/CT, Clin Radiol, 70, 536, 10.1016/j.crad.2014.12.020 Flukes, 2016, Positron emission tomography-positive thyroid nodules: rate of malignancy and histological features, ANZ J Surg, 86, 487, 10.1111/ans.12834 Reum Chun, 2015, Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography, endocrinol metab (seoul), 30, 71, 10.3803/EnM.2015.30.1.71 Cohen, 2001, Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography, Surgery, 130, 941, 10.1067/msy.2001.118265 Kim, 2005, 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma, Laryngoscope, 115, 1074, 10.1097/01.MLG.0000163098.01398.79 Are, 2007, FDG-PET detected thyroid incidentalomas: need for further investigation?, Ann Surg Oncol, 14, 239, 10.1245/s10434-006-9181-y Yang, 2012, Prevalence and risk of cancer of thyroid incidentaloma identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography, J Otolaryngol Head Neck Surg, 41, 327 Gavriel, 2014, Unfolding the role of PET FDG scan in the management of thyroid incidentaloma in cancer patients, Eur Arch Otorhinolaryngol, 272, 1763, 10.1007/s00405-014-3120-5 Jeong, 2010, Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study, Eur J Nucl Med Mol Imaging, 37, 2334, 10.1007/s00259-010-1571-5 Hyun, 2011, Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria, J Nucl Med, 52, 547, 10.2967/jnumed.110.083733 Sebro, 2013, Frequency and clinical implications of incidental new primary cancers detected on true whole-body 18F-FDG PET/CT studies, Nucl Med Commun, 34, 333, 10.1097/MNM.0b013e32835f163f Chopra, 2012, Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer, Br J Radiol, 85, e229, 10.1259/bjr/60606623 Ishimori, 2005, Detection of unexpected additional primary malignancies with PET/CT, J Nucl Med, 46, 752 Agarwal, 2014, A rare case of non–small cell lung cancer metastasizing to the pituitary gland: detection with 18F-FDG PET-CT, Clin Nucl Med, 39, e318, 10.1097/RLU.0b013e31828da679 Chittiboina, 2015, High-resolution18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease, J Neurosurg, 122, 791, 10.3171/2014.10.JNS14911 Karapolat, 2013, Clinically occult pituitary adenoma can appear as a hypermetabolic lesion on whole body FDG PEt imaging in a patient with lymphoma, Mol Imaging Radionucl Ther, 22, 18, 10.4274/Mirt.258 Maffei, 2012, A very rare case of nonfunctioning pituitary adenoma incidentally disclosed at 18F-FDG PET/CT, Clin Nucl Med, 37, e100, 10.1097/RLU.0b013e3182485217 Weng, 2011, Pituitary FDG uptake in a patient of lung cancer with bilateral adrenal metastases causing adrenal cortical insufficiency, Clin Nucl Med, 36, 731, 10.1097/RLU.0b013e31821a26bf Gemmel, 2010, Occult prolactinoma diagnosed by FDG PET/CT, Clin Nucl Med, 35, 269, 10.1097/RLU.0b013e3181d19098 Bancos, 2013, Evaluation of variables influencing the measurement of insulin-like growth factor-1, Endocr Pract, 20, 421, 10.4158/EP13359.OR Junnila, 2015, Pitfalls of insulin-like growth factor-I and growth hormone assays, Endocrinol Metab Clin North Am, 44, 27, 10.1016/j.ecl.2014.10.003 Soelberg, 2012, Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review, Thyroid, 22, 918, 10.1089/thy.2012.0005 Bertagna, 2013, F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centers on the significance of focal uptake and SUV value, Endocrine, 43, 678, 10.1007/s12020-012-9837-2 Eloy, 2009, The significance and management of incidental [18F] fluorodeoxyglucose–positron-emission tomography uptake in the thyroid gland in patients with cancer, AJNR Am J Neuroradiol, 30, 1431, 10.3174/ajnr.A1559 Fassett, 2004, Metastases to the pituitary gland, Neurosurg Focus, 16, 1 Hegerova, 2015, Metastasis to the thyroid gland: report of a large series from the mayo clinic, Am J Clin Oncol, 38, 338, 10.1097/COC.0b013e31829d1d09 Nakhjavani, 1997, Metastasis to the thyroid gland, Cancer, 79, 574, 10.1002/(SICI)1097-0142(19970201)79:3<574::AID-CNCR21>3.0.CO;2-# Lam, 1998, Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients, Arch Pathol Lab Med, 122, 37 Chen, 1999, Clinically significant, isolated metastatic disease to the thyroid gland, World J Surg, 23, 177, 10.1007/PL00013162